Regentis Biomaterials Ltd. Ordinary Shares (RGNT)

About RGNT

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment…

Sector

Health Care

Industry

Industrial Specialties

Fundamentals

1-day range

$1.65$1.73

Market cap

$13.84M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

75.3K

Regentis Biomaterials Ltd. Ordinary Shares Competitors

Chosen by industry and closest market cap.

• RGNT

  Regentis Biomaterials Ltd. Ordinary Shares

  $1.49

  ▼ 3.87%
  Market cap $13.84MP/E —
  $1.23$15.5
• BBLGW

  Bone Biologics Corp Warrants

  $7.7

  ▲ 0.00%
  Market cap $13.94MP/E —
  $3.5$35.95
• TLIH

  Ten-League International Holdings Limited Ordinary Shares

  $5.55

  ▼ 3.14%
  Market cap $16.94MP/E 2.95
  $2.2$6.74
• FGI

  FGI Industries Ltd. Ordinary Shares

  $7.49

  ▼ 0.27%
  Market cap $9.13MP/E —
  $3.14$19.93
• CUPR

  Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

  $1.9

  ▼ 2.56%
  Market cap $8.98MP/E —
  $1.45$14.8
• HSCS

  HeartSciences Inc. Common Stock

  $3.02

  ▼ 5.03%
  Market cap $7.80MP/E —
  $1.63$5.25
• LFWD

  Lifeward Ltd. Ordinary Shares

  $6

  ▼ 0.99%
  Market cap $20.93MP/E —
  $4.14$9.84

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Monday's Intraday Session
  Benzinga · 9/21/2026
• IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
  Yahoo · 9/18/2026
• Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
  Yahoo · 9/14/2026
• Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
  Yahoo · 9/11/2026
• Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
  Benzinga · 9/11/2026

• Cohen-Arazi Efraim · July 9, 2026 · Grant

  24.8K
• Dykan Jeff · July 9, 2026 · Grant

  24.8K
• Dykan Jeff · July 9, 2026 · Grant

  12.5K
• Valentine Keith · July 9, 2026 · Grant

  24.8K
• Ben-Elazar Pini · July 9, 2026 · Grant

  8.3K
• Ben-Elazar Pini · July 9, 2026 · Grant

  24.8K
• GELLER EHUD · July 9, 2026 · Grant

  31.3K
• Alpert Susan PHD MD · July 9, 2026 · Grant

  24.8K